Balancing Bleeding and Ischemic Risks: A Systematic Review of Dual Versus Triple Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
Abubakar Gapizov, Ahmad Mohammad, Shivam Singla, Bhavna Singla, Saifullah Syed, Sunita Kumawat, Zulqurnain Ali · 2025
Read Balancing Bleeding and Ischemic Risks: A Systematic Review of Dual Versus Triple Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation by Abubakar Gapizov, Ahmad Mohammad, Shivam Singla, Bhavna Singla, Saifullah Syed, Sunita Kumawat, Zulqurnain Ali (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12798678.txt.
Description
Abubakar Gapizov and co-authors review drug plans for patients who have both an irregular heartbeat and a stent in a heart artery in two thousand twenty-five. Such patients need drugs that stop clots, but more drugs also raise the risk of bleeding. The review weighs a two-drug plan against a three-drug plan.
Four trials were found that compare the two plans head-on. The two-drug plan, which pairs a newer blood thinner with one anti-platelet drug, cut bleeding in all of them. It did so without raising the rate of heart attack, stroke, or stent clots. The authors favor the two-drug plan for most patients, with short three-drug use kept for those at high clot risk.
Catalog record
| CREATOR | Abubakar Gapizov, Ahmad Mohammad, Shivam Singla, Bhavna Singla, Saifullah Syed, Sunita Kumawat, Zulqurnain Ali |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |